Blue Cap AG, a Munich-based investment company, announced a significant change to its Management Board. Dr. Henning von Kottwitz, Chairman of the Management Board, will leave the company effective October 8, 2026, by mutual agreement with the Supervisory Board. The Supervisory Board expressed its gratitude for his service and commitment. The company noted that it is well positioned for further development, particularly due to transactions implemented under Dr. von Kottwitz's leadership in recent years.
To ensure continuity, the Supervisory Board has resolved to second its Chairman, Dr. Christian Diekmann, to the Management Board as a member effective October 9, 2026, pursuant to Section 105(2) of the German Stock Corporation Act (AktG). He will be responsible for strategy and finance. Henning Eschweiler will remain a member of the Management Board as COO, continuing to oversee operational portfolio management, and will also assume responsibility for M&A from October 9, 2026.
Dr. Christian Diekmann has been Chairman of Blue Cap AG's Supervisory Board since 2024. He brings extensive experience in operational restructuring of medium-sized companies and the management and development of medium-sized corporate groups. He previously served as CEO of the listed Max Automation SE and CFO of the family-owned Zertus Group.
Dr. Michael Schieble, Deputy Chairman of the Supervisory Board, commented, "We are very pleased that Dr. Christian Diekmann has agreed to drive the further development of Blue Cap AG's business model as a member of the Management Board in the near term and take it to the next level. As Chairman of the Supervisory Board, he has in-depth knowledge of Blue Cap and understands its potential as a listed investment company pursuing the successful Buy-Transform-Sell strategy."
Dr. Diekmann added, "Blue Cap AG is ideally positioned as an investor in 'special situations' to grow in the current economic environment. Many companies that are fundamentally well positioned for the future are increasingly affected by disruptions in industry and structural challenges. We aim to address these challenges through our business model, strengthen Germany as an industrial location and create value for our shareholders. In my new role, I look forward to working even more closely with Blue Cap AG's highly qualified team."
The leadership transition comes at a time when Blue Cap AG sees opportunities in a challenging economic environment. As an investor in special situations, the company focuses on medium-sized B2B companies in the DACH region with revenues between EUR 20 million and EUR 200 million. Blue Cap currently holds majority stakes in six portfolio companies operating in plastics engineering, production engineering, pre-press solutions, life sciences, and business services, employing around 2,000 people across Germany, Europe, North America, and Asia.
The move underscores Blue Cap's commitment to its Buy-Transform-Sell strategy, which involves acquiring companies, supporting their development, and selling them at a profit later. With Dr. Diekmann's deep understanding of the company and its portfolio, the transition is expected to be smooth. Additional details are available on NEWMEDIAWIRE and the full release can be viewed on www.newmediawire.com.
